Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.
Katki
Hormuzd A
HA
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Gail
Mitchell H
MH
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Greene
Mark H
MH
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Electronic address: greenem@mail.nih.gov.
D051017:Apoptosis Regulatory Proteins; D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D008403:Mass Screening / Q000379:methods; D008957:Models, Genetic; D009154:Mutation; D016017:Odds Ratio; D010375:Pedigree; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors
D051017:Apoptosis Regulatory Proteins; C118024:BLID protein, human; D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human